Freedom Day Dividend ETF
MBOX - ETF AI Analysis
Top Page
Freedom Day Dividend ETF (MBOX)
MBOX (Freedom Day Dividend ETF) earns a solid overall rating, largely driven by strong, diversified dividend-paying leaders like Accenture, Exxon Mobil, and Travelers, which combine healthy financial performance with supportive earnings trends and income potential. However, holdings such as Kroger and Philip Morris, which face bearish technical signals, leverage concerns, and profitability or stability challenges, modestly weigh on the fund’s appeal, and the mix of overvaluation risks and sector-specific pressures is the main factor investors should watch.
MBOX vs. SPDR S&P 500 ETF (SPY)
- AUM
- 154.58M
- Region
- North America
- Expense Ratio
- 0.39%
- Beta
- 0.63
- Issuer
- Freedom Day
- Inception Date
- May 05, 2021
- Dividend Yield
- 1.86%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
MBOX Summary
The Freedom Day Dividend ETF (MBOX) is a U.S.-focused fund that invests across the total stock market with a special focus on companies that pay steady, growing dividends. It doesn’t track a specific index, but follows a dividend and “financial freedom” theme, holding a mix of large and smaller companies in sectors like financials, technology, energy, and health care. Well-known holdings include JPMorgan Chase and Exxon Mobil. Investors might consider MBOX for diversification plus potential income from dividends. A key risk is that stock prices and dividend payments can go up and down with the overall market.
How much will it cost me?
This ETF has an expense ratio of 0.39%, which means you’ll pay about $3.90 per year for every $1,000 you invest. That cost is higher than the average low-cost index ETF because MBOX is actively managed, focusing on dividend growth and financial freedom rather than simply tracking a broad market index.
What would affect this ETF?
This U.S.-focused ETF could benefit if the economy stays healthy, interest rates stabilize or fall, and dividend-paying sectors like financials, energy, and health care remain profitable, supporting companies such as JPMorgan, Exxon Mobil, and UnitedHealth. On the downside, rising interest rates, stricter regulations on banks, tobacco, or energy, or a broad market downturn could pressure dividends and share prices across its diversified holdings.
MBOX Top 10 Holdings
MBOX leans heavily on a mix of financials, tech, health care, and energy, with a few standout names doing the heavy lifting. Exxon Mobil and Marathon Petroleum have been rising steadily, giving the fund a strong energy engine, while Amgen and UnitedHealth add a healthy dose of defensive growth from the U.S. health care sector. Accenture and Dell bring an AI- and tech-driven edge, though Dell’s recent pullback shows that momentum can wobble. JPMorgan and Kroger are more mixed, occasionally lagging and keeping overall performance from running too far ahead.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 ACN | Accenture | 3.21% | $4.96M | $153.97B | 7.94% | 79Outperform |
 JPM | JPMorgan Chase | 2.86% | $4.43M | $888.27B | 6.72% | 72Outperform |
 AMGN | Amgen | 2.76% | $4.26M | $249.05B | 45.89% | 77Outperform |
 KR | Kroger Company | 2.72% | $4.21M | $39.98B | 6.73% | 56Neutral |
 ROP | Roper Technologies | 2.68% | $4.14M | $47.20B | 7.23% | 71Outperform |
 MO | Altria Group | 2.54% | $3.92M | $126.62B | 32.91% | 64Neutral |
 ADP | Automatic Data Processing | 2.48% | $3.83M | $119.75B | 20.21% | 70Outperform |
 PM | Philip Morris | 2.44% | $3.77M | $308.43B | 32.01% | 61Neutral |
 XOM | Exxon Mobil | 2.41% | $3.73M | $676.62B | 44.86% | 74Outperform |
 TRV | Travelers Companies | 2.37% | $3.67M | $80.99B | 43.05% | 78Outperform |
MBOX Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For MBOX, the sentiment is Neutral. The current price of 41.98 is below the 20-day moving average (MA) of 42.25, above the 50-day MA of 41.62, and above the 200-day MA of 39.52, indicating a neutral trend. The MACD of 0.33 indicates Positive momentum. The RSI at 48.75 is Neutral, neither overbought nor oversold. The STOCH value of 33.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for MBOX.
MBOX Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| MBOX | $41.98 | $47.00(11.95% Upside) | $154.58M | 0.39% | 73Outperform |
 SEUS | $25.11 | $30.33(20.78% Upside) | $915.80M | 0.30% | 73Outperform |
 BGDV | $30.54 | $36.07(18.11% Upside) | $850.39M | 0.45% | 74Outperform |
 AAUB | $48.46 | $59.38(22.54% Upside) | $800.00M | 0.10% | 66Neutral |
 AVTM | $52.23 | $62.91(20.44% Upside) | $741.01M | 0.22% | 60Neutral |
 SMRI | $46.51 | $55.75(19.87% Upside) | $701.29M | 0.71% | 73Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| MBOX | Freedom Day Dividend ETF | 41.98 | 7.61 | 22.15% | |
| SEUS | SEI QiM U.S. Equity Factor Allocation Active ETF | 25.11 | -0.15 | -0.60% | |
| BGDV | Bahl & Gaynor Dividend ETF | 30.54 | 3.68 | 13.70% | |
| AAUB | Alpha Architect US Equity 4 ETF | 48.46 | -1.02 | -2.07% | |
| AVTM | Avantis Total Equity Markets ETF | 52.23 | 2.59 | 5.21% | |
| SMRI | Bushido Capital US Equity ETF | 46.51 | 11.44 | 32.62% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.